What We're Reading: Page 312
Industry reads hand-picked by our editors
Sep 29, 2016
Sep 28, 2016
-
The New York Times
Furor over drug prices puts patient advocacy groups in bind
-
The Wall Street Journal
Physicians and physicists join forces to fight pancreatic cancer
-
Xconomy
New Rockefeller prez takes stock of 'wildly underdeveloped' NY bio scene
-
Stat
From FDA expert to biotech insider: The drug industry thrives on the revolving door
Sep 27, 2016
Sep 26, 2016
Sep 23, 2016
Sep 22, 2016
-
Bloomberg
Juno spends big on R&D, production in CAR-T race to fight cancer
-
Stat
Secret trove reveals bold ‘crusade’ to make OxyContin a blockbuster
-
Reuters
UK okays Alexion drug costing up to $2 million but wants price cut
-
Wall Street Journal
Big Pharma's big checkbooks drive biotech resurgence
-
In the Pipeline
The Chan-Zuckerberg Initiative
Sep 21, 2016
-
BloombergGadfly
Allergan is making biotech expensive again
-
EP Vantage
Expect Glaxo to increase consumer focus as Walmsley takes driving seat
-
The Street
Cloudy outlook for Aerie Pharma's glaucoma drug
Previous
